Match Document Document Title
5861048 Phosphorylated saccharide and method for producing the same  
Phosphorylated saccharide of the present invention includes at least one phosphate group in its molecule, selected from the group consisting of glucan, mannan, dextran, agar, cyclodextrin,...
5859066 Method for the treatment of itching  
A method useful for the treatment of itching is disclosed. The method comprises applying an effective amount a 1,4-naphthoquinone to the affected area of the skin. The 1,4-naphthoquinone is hydroxy...
5858985 Treatment of asthma with fructose-1,6-diphosphate  
Fructose-1,6-diphosphate (FDP), a sugar-phosphate compound, can be useful in treating asthma, when administered as an inhalable drug, either by itself or as a component of a mixed formulation. On a...
5856299 Highly reactive esters of carboxy polysaccharides and carboxy polysaccharides derived therefrom  
Provided are active esters of carboxy polysaccharides and semisynthetic derivatives of carboxy polysaccharides, wherein all or part of the carboxy groups thereof are esterified with an aromatic...
5853737 Method for inducing a CD1-restricted immune response  
The present invention is based on the observation that CD1 functions to present foreign and autoimmune antigens to a select subpopulation of T-cells. Based on this observation, the present...
5849336 Method using sturgeon notochord for alleviating the symptoms of arthritis  
This invention provides a composition comprising notochord and extracts thereof in therapeutic amounts. The invention more specifically relates to a method of treating arthritis in mammals, more...
5849859 Polyesters  
A biodegradable and biocompatible polyester comprising (C 3 -10) alkylene carbonic acid ester units, each alkylene group being a C 3 -alkylene group having 1 oxy substituent or a (C 4 -10)...
5849274 Stable light protection preparations containing surface-active glucose derivatives and water-soluble UV filters  
Cosmetic or pharmaceutical O/W emulsions which contain (a) one or more surface-active substances selected from the group consisting of glucose derivatives of the structural formula ##STR1## in...
5849709 Saccharopeptides and derivatives thereof  
Saccharopeptides and methods of using the novel saccharopeptides are described having the following structural formula I: W-- --Y--W--! m (I) wherein W is...
5846548 Combined administration of mitogenic immumo stimulator and a thymomimetic  
A method of tumor therapy involves controlling the immune system by co-administration of a mitogenic immuno-stimulating substance and a thymomimetic substance.
5846572 Body fluid replacement solution  
A sterile, pyrogen-free fluid replacement solution for intravenous infusion is disclosed that consists essentially of a physiologically acceptable sodium salt, a physiologically acceptable...
5843907 Pharmaceutical composition containing 2-O-α-d-glucopyranosyl-l-ascorbic acid  
2-O-α-D-Glucopyranosyl-L-ascrobic acid is crystallizable in its supersaturated solution. Crystalline 2-O-α-D-glucopyranosyl-L-ascorbic acid is substantially nonhygroscopic, free flowing, free of...
5843937 DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents  
The present invention relates to novel DNA alkylating agents and the prodrugs of these agents which are useful as antitumor agents and DNA labelling agents. The compounds are hydroxy...
5840703 Phase transfer catalyst for use in the synthesis of polyol fatty acid polyesters  
A reaction mixture for manufacturing polyol fatty acid polyesters comprises a polyol, a fatty acid lower alkyl ester, a base initiator and a phase transfer catalyst. The phase transfer catalyst can...
5840702 Cystic fibrosis treatment  
The present invention provides a method of stimulating expression of a functional full-length cystic fibrosis transmembrane conductance regulator protein in an individual in need of such treatment,...
5840770 Method of killing tumor cells  
This invention provides an immunoenhancement or immune-potentiation therapy comprising administration of potassium, insulin, glucose and, optionally, thyroid, a cholinergic agent and bicarbonate....
5837695 Fluorescent chlamydia antigen substrate  
The present invention relates to a unique fluorescently labeled Chlamydial antigen. This fluorescently labeled Chlamydial antigen is useful in immunoassay-type formatted systems for the detection...
5834436 Membrane-permeant second messengers  
Acyloxyalkyl esters of phosphate-containing second messengers which are capable of permeating cell membranes. Once inside the cell, the ester derivatives undergo enzymatic conversion to the...
5834437 Asiatic acid derivatives its manufacturing method and dermatological agent containing it  
The object of the present invention is to provide asiatic acid derivatives, its pharmaceutically acceptable salts or esters. Asiatic acid, its trisaccharide asiaticoside and mddecassic acid,...
5834444 Hyaluronic acid and salts thereof inhibit arterial restenosis  
A method is provided of preventing arterial restenosis of an animal after the arteries have been traumatized. The method comprises the administration of a therapeutically effective non-toxic amount...
5833960 Foaming light protection preparations containing water-soluble light protection filters and surface-active substances  
Active substance combinations of (a) one or more surface-active substances selected from the group comprising glucose derivatives, (b) one or more surface-active substances selected from the...
5830871 Inhibitors of E-, P- and L-selectin binding  
Inhibitors of E-, P- and L-selectin binding are synthesized by an aldol addition reaction between a glycoside aldehyde precursor and dihydroxyacetone phosphate or a derivative thereof. The addition...
5830872 Esters of D-mannose or of xylitol and their use as medicaments  
Esters associating phenylacetic, 3-phenylpropionic, 4-phenylbutyric and n-butyric acids with Su(OH) n monosaccharides or sugar alcohols, of general formula (I), in which the Su(OH) n precursor is...
5827820 Aqueous peritoneal dialysis solution  
The subject matter of this invention concerns an aqueous peritoneal dialysis solution which is obtained immediately prior to administration from two individual solutions, the first of which...
5817695 Nutritional product with high fat, low carbohydrate and amino acid imbalance  
A nutritional product is provided for cancer patients comprising, as per caloric requirement, a low concentration of carbohydrate, a high concentration of fat and an imbalance of amino acids...
5814664 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advanced glycosylation endproducts and methods of use therefor  
The present invention relates to advanced glycosylation endproducts, and particularly to the use of novel cyclopentenone aminoreductones, 3-alkylamino-2...
5811403 Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity  
The invention relates to a polysaccharide toxin from group B β-hemolytic Streptococcus (GBS) having improved purity. The improved purity of the toxin, 95%, is achieved by the method of...
5811405 Multiply fucosylated dicarboxylic acids possessing antiadhesive properties  
The invention relates to multiply fucosylated dicarboxylic acid derivatives possessing antiadhesive properties, to a process for preparing them, to their use, and to pharmaceuticals and diagnostic...
5807555 Skin treatments with Smelophyllum capense extracts  
The present invention relates to a method and composition for topically administering a Smelophyllum capense extract as a cosmetic, dermatologic, or pharmaceutical composition to promote collagen...
5807847 Nitrate esters  
Aliphatic Nitrate esters having a sulfur or phosphorus atom β or γ to a nitrate group having efficacy as vasodilators are described. Preferred nitrate esters may be synthesized by nitration of a...
5807951 Pharmaceutical composition regulating function of a living body  
The present invention provides silicate polymers which regulate the function of a living body by restoring and normalizing the lowered cell functions due to diseases. The silicate polymers are...
5801151 Estimation of ovular fiber production in cotton  
The present invention is a method for rendering cotton fiber cells that are post-anthesis and pre-harvest available for analysis of their physical properties. The method includes the steps of...
5798343 7-O-Carbamoylheptose derivatives, process for their production and their use in treating pseudomonas infections  
The invention describes 7-O-carbamoyl heptose derivatives of general formula (I) in which R is the substituent R 1 or a group of general formula (II) in which R 1 is a hydrogen atom, a methyl...
5792753 Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs  
A topically administrable pharmaceutical composition is disclosed which comprises a therapeutically effective amount of a drug which inhibits prostaglandin synthesis, and an amount of a form of...
5792754 Nutritional composition containing fibres  
A nutritional composition, suitable for enteral administration, is described which contains 5-120 g of composite dietary fibre per daily dosage of the composition or per 2000 kcal, which fibre...
5783189 Method for treating alcohol dependence  
Isoflavonoids containing a carbon-carbon linked β-D-glucose moiety at the C-8 position and isolated from the Chinese herbal plant Pueraria lobata are useful for treating alcohol dependence.
5780442 Orthosomycins from micromonospora carbonacae  
Orthosomycins have been isolated from the fermentation broth of the microorganism Micromonospora Carbonacea var Africana designated SCC 2146. These compounds are antibacterial agents. Compositions...
5776503 Amino acid solutions for treatment of peritoneal dialysis patients  
The present invention provides a dialysis solution that contains amino acids for treating and/or preventing malnutrition in a peritoneal dialysis patient. The amino acid composition is optimized to...
5776887 Diabetic nutritional product having controlled absorption of carbohydrate  
Nutritional composition for use by diabetics containing a controlled absorbed carbohydrate component. The carbohydrate component contains a rapidly absorbed fraction such as glucose or sucrose, a...
5770223 Method of treatment for combatting the effects of aging on the condition of skin and hair  
The invention relates to the use of Medicago saponins for the preparation of cosmetic or pharmaceutical compositions. The invention provides for the incorporation of 0.01% to 5% by weight of a...
5767268 Sulfuric acid esters of amino sugars  
Compounds of formulas ##STR1## wherein, B is lower alkylene or an optionally substituted aromatic ring system; G 1 , G 2 and G 3 each independently signify a residue of a glycopyranoside, a...
5767091 Analgesic effect enhancing preparations  
The present invention provides an analgesic effect enhancing preparation capable of enhancement of the effect of analgesics, the preparation comprising as an active ingredient the following amino...
5767090 Microbially produced rhamnolipids (biosurfactants) for the control of plant pathogenic zoosporic fungi  
Disclosed is the use of biosurfactants as biological control products. In particular, rhamnolipid biosurfactants produced by Pseudomonas spp. were demonstrated to rapidly kill zoospores by...
5766578 Axillary malodor neutralization  
A method of neutralizing axillary malodor by contacting the malodor with a sulfhydryl reactant.
5767104 Use of sulfated saccharides to treat baldness  
A method of treating and/or preventing alopecia (baldness, deficient hair growth) comprises administering to a patient in need thereof a therapeutically or prophylactically effective amount of a...
5763412 Film-forming composition containing chlorhexidine gluconate  
An antimicrobial film forming surgical site preparation composition includes a film forming material and an antimicrobial agent soluble in a fugitive solvent. The composition when applied to the...
5760005 Stabilized caloric nutrient solution and a multicompartmental system or multiple recipient for human parenteral nourishing  
The invention relates to a caloric nutrient solution for human parenteral nourishing, containing at least one reducing sugar and a stabilizer for the sugar or sugars and, if desired, further...
5759579 Pharmaceutical suspension systems  
A pharmaceutically acceptable liquid suspension system is provided for solid finely divided pharmaceutical actives incompletely soluble in water, the suspension system comprising water, xanthan gum...
5760008 Method and compositions for treating malignant tumors and inhibiting metastases of malignant tumors  
According to the present invention, a substrate for cytochrome p450 which, after oxidation by cytochrome p450, reacts with thiol groups is conjugated to a saccharide to provide a tumor-specific...
5760006 Anticonvulsant derivatives useful in treating psoriasis  
The use of compounds of the following formula I: ##STR1## for treating psoriasis is disclosed.